STAAR Surgical (STAA) Upgraded at Zacks Investment Research

Quantum Capital Management grew its stake in STAAR Surgical by 45.8% during the first quarter. Quantum Capital Management now owns 72,655 …

STAAR Surgical logoZacks Investment Research upgraded shares of STAAR Surgical (NASDAQ:STAA) from a hold rating to a strong-buy rating in a research note published on Tuesday morning, Zacks.com reports. The brokerage currently has $29.00 price target on the medical instruments supplier’s stock.

According to Zacks, “Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. “

Other equities analysts also recently issued reports about the stock. BidaskClub upgraded shares of STAAR Surgical from a hold rating to a buy rating in a research note on Wednesday, February 20th. Canaccord Genuity restated a buy rating and issued a $38.00 price target (down from $43.00) on shares of STAAR Surgical in a research note on Monday. Finally, ValuEngine upgraded shares of STAAR Surgical from a hold rating to a buy rating in a research note on Wednesday, May 1st. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. STAAR Surgical has a consensus rating of Buy and an average price target of $40.33.

Shares of STAA traded down $1.30 during trading hours on Tuesday, hitting $25.96. The company had a trading volume of 27,435 shares, compared to its average volume of 447,169. The firm has a market capitalization of $1.21 billion, a PE ratio of 91.82 and a beta of 2.02. STAAR Surgical has a 12 month low of $21.70 and a 12 month high of $54.00. The company has a debt-to-equity ratio of 0.04, a current ratio of 5.41 and a quick ratio of 4.83.

STAAR Surgical (NASDAQ:STAA) last issued its quarterly earnings data on Wednesday, May 1st. The medical instruments supplier reported $0.10 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.04 by $0.06. The company had revenue of $32.58 million for the quarter, compared to analyst estimates of $32.40 million. STAAR Surgical had a net margin of 4.44% and a return on equity of 13.22%. During the same period in the prior year, the firm earned $0.01 earnings per share. Analysts predict that STAAR Surgical will post 0.33 earnings per share for the current fiscal year.

In other STAAR Surgical news, CTO Keith Holliday sold 2,084 shares of the stock in a transaction dated Tuesday, March 19th. The shares were sold at an average price of $36.22, for a total transaction of $75,482.48. Following the sale, the chief technology officer now directly owns 40,239 shares in the company, valued at $1,457,456.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Broadwood Partners, L.P. acquired 100,000 shares of STAAR Surgical stock in a transaction on Friday, May 3rd. The shares were purchased at an average price of $22.23 per share, for a total transaction of $2,223,000.00. The disclosure for this purchase can be found here. Insiders sold 17,730 shares of company stock worth $655,538 over the last 90 days. 3.90% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently made changes to their positions in the business. Great West Life Assurance Co. Can grew its stake in STAAR Surgical by 46.8% during the first quarter. Great West Life Assurance Co. Can now owns 5,172 shares of the medical instruments supplier’s stock worth $176,000 after buying an additional 1,649 shares in the last quarter. Cadence Capital Management LLC grew its stake in STAAR Surgical by 66.7% during the first quarter. Cadence Capital Management LLC now owns 113,410 shares of the medical instruments supplier’s stock worth $3,877,000 after buying an additional 45,387 shares in the last quarter. Quantum Capital Management grew its stake in STAAR Surgical by 45.8% during the first quarter. Quantum Capital Management now owns 72,655 shares of the medical instruments supplier’s stock worth $2,484,000 after buying an additional 22,809 shares in the last quarter. Victory Capital Management Inc. acquired a new stake in STAAR Surgical during the first quarter worth about $186,000. Finally, Comerica Bank grew its stake in STAAR Surgical by 7.5% during the first quarter. Comerica Bank now owns 37,197 shares of the medical instruments supplier’s stock worth $1,377,000 after buying an additional 2,600 shares in the last quarter. Hedge funds and other institutional investors own 90.99% of the company’s stock.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.

Read More: What is a resistance level?

Get a free copy of the Zacks research report on STAAR Surgical (STAA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for STAAR Surgical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for STAAR Surgical and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Broadcom Inc. (AVGO) stock price at $304.06 to 0.22% and 20 day SMA of -3.15%

Broadcom Inc. (AVGO) stock is growing 0.22% to $304.06. … Broadcom Inc. (AVGO) recently closed with fall of -3.15% to its 20-Day “SMA”. This short …

Broadcom Inc. (AVGO) stock go up so far this year; showing a rise of 19.58% and dropped with negative flow of -3.72% during recent week. The shares price has positioned 13.00% up over the past quarter while it has directed 38.15% toward a rising position throughout past six months. The shares price has directed 27.30% toward a higher level throughout last year and swapped 0.20% toward a strong spot during past one month.

Broadcom Inc. (AVGO) stock is growing 0.22% to $304.06. AVGO exchanged 2.23 million shares in recent session versus to the average volume of 2.48 million shares while its relative volume is 0.88. The company holds 397.64 million outstanding shares and 384.74 million shares are floating in market.

EPS in next five year years is expected to touch 15.61% while EPS growth in past 5 year was 39.60% along with sales growth of 52.60% in the last five years. EPS growth in next year is estimated to reach 14.23% while EPS growth estimate for this year is set at 187.60%.

The PE ratio of 26.40 helps investors explore how much they should pay for a stock based on its current earnings. High ratio reveals positive future performance and investors are willing to pay more. Low ratio discloses poor current and future performance. The price earnings ratio (P/E) ratio helps investors analyze how much they should pay for a stock based on its current earnings. The ROA is 11.40%. A company that manages their assets well will have a high return, while if manages their assets poorly will have a low return. ROI is 13.20%. A positive result means that returns exceed costs. Analysts therefore consider the investment a net gain. The opposite kind of result, a negative means that costs outweigh returns. Analysts therefore view the investment as a net loss.

Experts have a mean recommendation of 2.00 on this stock. This is based on a 1-5 numeric scale where Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell.

20-Day Simple Moving Average:

Broadcom Inc. (AVGO) recently closed with fall of -3.15% to its 20-Day “SMA”. This short time frame picture represents a downward movement of current price over average price of last 20 days. 20-day simple moving average is useful at identifying swing trading trends lasting 20 days.

50-Day Simple Moving Average:

50-day “SMA” is more useful at showing position trading trends lasting 50 days. Shares of AVGO moved upward with change of 1.99% to its 50-day Moving average. This rising movement shows positive prices direction over last 50 days.

200-Day Simple Moving Average:

200-day “SMA” is more helpful at telling general investing trends lasting 200 days. Longer moving average timeframes are less sensitive to price fluctuations than shorter term timeframes and will generate far few signals. This will reduce the number of “whipsaws”, which is good, but will also generate signals later than when using shorter term averages. AVGO stock price revealed optimistic move of 19.78% comparing average price of last 200 days. This comparison showed up direction of price above its 200-SMA.

The beta factor is 0.69. Volatility shows sense of how far the stock will fall if the market takes a dive and how high stock will rise if the bull starts to climb. A stock with a beta more than 1 means high volatile and less than 1 means low volatile.

Edgar gives us an insight into the most recent news hitting the Technology Sector in Wall Street Market. He has been an independent financial adviser for over 10 years in the city and in recent years turned her experience in finance and passion for journalism into a full-time role. He performs analysis of Companies and publicizes valuable information for shareholder community.

Edgar is an accomplished journalist who has a passion for travel. His desire to see the world has taken him to countries around the world and given him the opportunity to report for some of the top news organizations.

Related Posts:

  • No Related Posts

What’s in Store For Juniper Networks, Inc. (NYSE:JNPR) According to Analysts?

Looking further at shares of Juniper Networks, Inc. (NYSE:JNPR), we have noticed that the current consensus target price is $27.82. Wall Street …

Investors may be getting ready to review the most recent company earnings reports. Digging down into the numbers may help provide a good idea of how the company is set up for the foreseeable future. After a recent scan, we can see that the current quarter EPS consensus estimate for Juniper Networks, Inc. (NYSE:JNPR) is 0.4. This EPS estimate is using estimates provided by 11 sell-side analysts polled by Zacks Research. For the previous reporting period, the company posted a quarterly EPS of 0.26. Investors and analysts will be closely watching to see what kind of impact the earnings results have on the stock after the next report.

As company earnings reports continue to roll in, investors will be watching to see which companies hit their numbers for the last reporting period. Investors will also be watching which sectors are reporting the best earnings numbers. A positive overall earnings season could mean that the stock market could keep climbing. Many investors may be cautious with the market trading at current levels. Even though the gloom and doom prognosticators are out in full force, investors have to do the research and decide for themselves which way they believe the market will move in the next couple of months.

Looking further at shares of Juniper Networks, Inc. (NYSE:JNPR), we have noticed that the current consensus target price is $27.82. Wall Street analysts have the ability to create price target estimates for where they think the stock will be moving in the near-term. Because price target projections can differ from one analyst to the next, they may span a wide range of values. Many investors will closely track target prices, and they tend to pay extra close attention when analysts make revisions to those targets.

Just-released reportnames Cannabis Stock of the Year for 2019!Their last pick has seen a +1,200% return since he released it!

This stock has all of the makings of the next great cannabis stock – early-mover advantage, international exposure and influential partnerships, plus it has a product that isunlike anything else on the market…

You will also receive a free, weekly newsletter to stay on top of the latest industry trends, read analysis on promising cannabis stocks, and more.Click here to receive your Free Report immediately!

Wall Street analysts often give buy/sell/hold ratings for the companies that they track. Investors have the ability to view these sell-side ratings in order to help with their own stock research. Analyst ratings may have different interpretations. According to analysts polled by Zacks Research, the current average broker rating on shares of Juniper Networks, Inc. (NYSE:JNPR) is 2.87. This rating uses a scale between 1 and 5. Following this scale, a rating of 1 would represent a Strong Buy, and a rating of 5 would indicate a Strong Sell recommendation. Out of all these analysts offering ratings, 4 have rated the stock a Strong Buy or Buy, according to Zacks Research.

Shifting the focus to some possible support and resistance levels on shares of Juniper Networks, Inc. (NYSE:JNPR), we note that the 52-week high is currently $30.67, and the 52-week low is currently $25.56. When shares are trading near to the 52-week high or 52-week low, investors may be watching for a break through either level. Investors may also be watching historical price action. Over the past 12 weeks, the stock has moved -1.97%. Going back to the start of the year, we can see that shares have moved -1.78%. Over the last 4 weeks, shares have seen a change of -3.93%. Over the last 5 trading days, the stock has moved -5.17%. Checking in on recent session activity, we have seen that the stock has been trading near the $26.43 mark.

When undertaking stock analysis, investors might be searching for companies that are presently undervalued. Undervalued stocks may provide a higher chance of realizing big gains. Finding undervalued stocks that are high quality can be the biggest challenge for the investor. Many investors will dig into the numbers and look for companies that have been consistently making lots of money and performing well on the earnings front.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Technology Stock Recap: NXP Semiconductors NV (NXPI)

NXP Semiconductors N.V. (NXPI):. Share of NXP Semiconductors N.V. (NXPI) stock price is settled at $100.33 after trading hours. Taking a look at the …

NXP Semiconductors N.V. (NXPI) stock gained attention from Active Investors. Active investors purchase investments and continuously monitor their activity in order to exploit profitable conditions. Active investing is highly involved. Unlike passive investors, who invest in a stock when they believe in its potential for long-term appreciation, active investors will typically look at the price movements of their stocks many times a day. Typically, active investors are seeking short-term profits. Active investing is an investment strategy involving ongoing buying and selling actions by the investor typically for no more than one day.

The stock dispatched 10.58% performance during the quarter and performance arrived at 21.08% over the last six months. In the last month, the price performed 2.81%. Shares are now at 1.56% over the past year and year to date performance pointed at 36.91%. Contracting the focus on performance, delivered a move of -5.88% over the last week.

The stock has a beta of 1.11 compared to a beta of 1 for the market, which implies that the stock’s price movements are more extreme than the market as a whole. The stock therefore has above average level of market risk. During the past week, the stock’s average weekly volatility was 3.19% and 2.69% volatility over the past 30 days.

Wall Street Analysts suggested rating of 2.3. This rating is on a scale of 1 to 5. A rating of a 1 or a 2 would signify a mean Buy view. A rating of 4 or 5 would specify a mean Sell opinion. A rating of 3 would show a mean Hold recommendation. Captivating a peek at sell-side analyst insights, we can understand that the recent mean target price for the company is $103.68.

Hot StocksNXP Semiconductors N.V.,NXPI

  • Daniel JohnsonDaniel Johnson studied a business degree majoring in finance and security analysis. He has a deep understanding of both technical and fundamental forms of analysis, he deeply believes that it makes a lot more sense for average investors to understand fundamental analysis, which he believes anyone can learn. Daniel has over 10 years of experience as a professional journalist, writer and an editor. He holds a bachelor’s degree in International Business from University of Melbourne. He writes articles about hot stocks, dividend growth investing, options trading, investment decisions, stock selection, portfolio management, and passive income generation. Daniel primarily reports on Hot Stocks category.Email Contact: Daniel@stockdigest.info
  • Douglas Emmett (DEI): Worth Watching Financial Stock:

    Douglas Emmett (DEI): Every trading day indicate diverse behavior and trends about Douglas Emmett (DEI) stock. Now we observed the […]

  • Brown & Brown (BRO): Financial Stock Recap:

    Brown & Brown (BRO): Checking on recent price levels compared to prior highs and lows, we have seen that Brown […]

  • Stock in the Spotlight: Lite Access Technologies Inc. (OTC:LTCCF)

    Lite Access Technologies Inc. (OTC:LTCCF) Lite Access Technologies Inc. (OTC:LTCCF) stock price is settled at $0.247 in recent trading activity. […]

  • Scan Stocks Buzz: Snam S.p.A. (OTC:SNMRY)

    Snam S.p.A. (OTC:SNMRY) Shares are now at 9.130913% over the past year and five years performance pointed at -19.218241%. The […]

  • Post navigation

    Intraday Healthcare Mover: Proteostasis Therapeutics (PTI)
    TechnipFMC plc (FTI): Basic Materials Stock Roundup:

    Leave a Reply Cancel reply

    Your email address will not be published. Required fields are marked *
    Comment